| Tap a line for its trend | Last 12Mto Jun 2026 | FY26Mar 2026 | FY25Mar 2025 | FY24Mar 2024 | FY23Mar 2023 | FY22 and earlierAlpha Plus |
|---|
| 53.47× | 53.47× | 139.34× | 247.50× | 110.23× | FY22 and earlierEvery year the company has filed comes with Alpha Plus. | |
| 3.54× | 2.84× | 0.26× | 0.22× | 2.34× | ||
| 0.45× | 0.45× | 0.12× | 0.08× | 0.14× | ||
| −0.75× | −0.75× | 1.91× | −6.24× | −0.06× | ||
| −0.83× | −0.83× | 1.08× | −20.28× | 1.24× |
From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.
Ratios — % unless marked × 12 Months Ending | FY23 31/03/2023 | FY24 31/03/2024 | FY25 31/03/2025 | FY26 31/03/2026 | Last 12M 30/06/2026 | |
|---|---|---|---|---|---|---|
| Receivable Days (DSO) | 110.23 | 247.50 | 139.34 | 53.47 | 53.47 | |
| Working Capital Turnover | 2.34 | 0.22 | 0.26 | 2.84 | 3.54 | |
| Asset Turnover | 0.14 | 0.08 | 0.12 | 0.45 | 0.45 | |
| Cash Conversion (CFO/Net Income) | -0.06 | -6.24 | 1.91 | -0.75 | -0.75 | |
| CFO/EBITDA | 1.24 | -20.28 | 1.08 | -0.83 | -0.83 |